Hypopharyngeal cancer

Topics in Magnetic Resonance Imaging

Volumn 18, Issue 4, 2007, Pages 243-258

  Wycliffe, Nathaniel D ^a   Grover, Ryan Shane ^b   Kim, Paul D ^a   Simental Jr , Alfred ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hypopharyngeal cancer; Radiological imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; SUPERPARAMAGNETIC IRON OXIDE;

CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; HUMAN; HYPOPHARYNX CANCER; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; REVIEW; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

HUMANS; HYPOPHARYNGEAL NEOPLASMS; HYPOPHARYNX; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34748878811     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e3181570c3f     Document Type: Review

References (138)

1. Wahlberg PC, Andersson KE, Biorklund AT, et al. Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30-year period. Head Neck. 1998;20:714-719.
2. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer. 1995;75:147-153.
3. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2004. Available at: http://seer.cancer.gov/csr/1975_2004/. Bethesda, MD: National Cancer Institute. Accessed April 16, 2007.
4. Ries LAG, Eisner MP, Kosary CL, et al. SEER Cancer Statistics Review, 1973-1998. Bethesda, MD: National Cancer Institute; 2001.
5. Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg. 2006;135:451-457.
6. Siddiqui F, Sarin R, Agarwal JR, et al. Squamous carcinoma of the larynx and hypopharynx in children: a distinct clinical entity? Med Pediatr Oncol. 2003;40:322-335.
7. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282-3287.
8. Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994;86:131-137.
9. Mendenhall WM, Riggs CE Jr, Cassisi NJ. Treatment of head and neck cancers. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:662-732.
10. Wynder EL, Hultberg S, Jacobsson F, et al. Environmental factors in cancer of the upper alimentary tract; a Swedish study with special reference to Plummer-Vinson (Paterson-Kelly) syndrome. Cancer. 1957;10:470-487.
11. Ahlbom HE. Simple achlorhydric anaemia, Plummer-Vinson syndrome, and carcinoma of the mouth, pharynx, and oesophagus in women. Br Med J. 1936;2:331-333.
12. Larsson LG, Sandström A, Westling P. Relationship of Plummer-Vinson disease to cancer of the upper alimentary tract in Sweden. Cancer Res. 1975;35:3308-3316.
13. Amos A. Women and smoking. Br Med Bull. 1996;52:74-89.
14. Morgan DW, Abdullah V, Quiney R, et al. Human papilloma virus and carcinoma of the laryngopharynx. J Laryngol Otol. 1991;10:288-290.
15. Bradfor CR, Hoffman HT, Wolf GT, et al. Squamous carcinoma of the head and neck in organ transplant recipients: possible role of oncogenic viruses. Laryngoscope. 1990;100:190-194.
16. Spitz MR, Lippman SM, Jian H, et al. Mutagen sensitivity as a predictor of tumor recurrence in patients with cancer of the upper aerodigestive tract. J Natl Cancer Inst. 1998;90:243-245.
17. Ward PH, Hanson DG. Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope. 1988;98:1195-1199.
18. Berrino F, Richiardi L, Boffetta P, et al. Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control. 2003;14:213-223.
19. Oral cavity and oropharynx. In: Rosai J, ed. Ackerman's Surgical Pathology. 8th ed. St. Louis, MO: Mosby; 1996:223-255.
20. Stanley RJ, Weiland LH, DeSanto LW, et al. Lymphoepithelioma (undifferentiated carcinoma) of the laryngohypopharynx. Laryngoscope. 1985;95:1077-1081.
21. McKay MJ, Bilous AM. Basaloid-squamous carcinoma of the hypopharynx. Cancer. 1989;63:2528-2531.
22. Frank DK, Cheron F, Cho H, et al. Nonnasopharyngeal lymphoepitheliomas (undifferentiated carcinomas) of the upper aerodigestive tract. Ann Otol Rhinol Laryngol. 1995;104:305-310.
23. Olsen KD, Lewis JE, Suman VJ. Spindle cell carcinoma of the larynx and hypopharynx. Otolaryngol Head Neck Surg. 1997;116:47-52.
24. Helliwell TR. Acp Best Practice No 169. Evidence based pathology: squamous carcinoma of the hypopharynx. J Clin Pathol. 2003;56:81-85.
25. Goldenberg D. Cancer of the Hypopharynx. [E-Medicine from WebMD]. Feb 9, 2007. Available at: http://www.emedicine.com/ent/topic783.htm. Accessed April 17, 2007.
26. Kleinsasser O. Tumors of the Larynx and Hypopharynx. Stuttgart: Georg Thieme; 1988.
27. Barnes L, Johnson JT. Pathologic and clinical considerations in the evaluation of major head and neck specimens resected for cancer. Part I. Pathol Annu. 1986;21:173-250.
28. Jones RF. The Paterson-Brown Kelly syndrome. Its relationship to iron deficiency and postcricoid carcinoma. I. J Laryngol Otol. 1961;75:529-543.
29. Anderson SR, Sinacori JT. Plummer-Vinson syndrome heralded by postcricoid carcinoma. Am J Otolaryngol. 2007;28:22-24.
30. Jones AS, Stell PM. Squamous carcinoma of the posterior pharyngeal wall. Clin Otolaryngol Allied Sci. 1991;16:462-465.
31. Keberle M, Kenn W, Hahn D. Current concepts in imaging of laryngeal and hypopharyngeal cancer. Eur Radiol. 2002;12:1672-1683.
32. Zbaren P, Becker M, Lang H. Pretherapeutic staging of hypopharyngeal carcinoma. Clinical findings, computed tomography, and magnetic resonance imaging compared with histopathologic evaluation. Arch Otolaryngol Head Neck Surg. 1997;123:908-913.
33. Zbaren P, Becker M, Lang H. Staging of laryngeal cancer: endoscopy, computed tomography and magnetic resonance versus histopathology. Eur Arch Otorhinolaryngol. 1997;254:S117-S122.
34. Becker M, Zbaren P, Laeng H. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology. 1995;194:661-669.
35. Castelijns JA, van den Brekel MW, Hermans R. Imaging of the larynx. Semin Roentgenol. 2000;35:31-41.
36. Sievers KW. Rational imaging strategies in laryngeal diseases. Radiologe. 1998;38:77-82.
37. Castelijns JA, van den Brekel MW, Smit EMT, et al. Predictive value of MR imaging-dependent and non-MR imaging-dependent parameters for recurrence of laryngeal cancer after radiation therapy. Radiology. 1995;196:735-739.
38. Castelijns JA, Brekel M, Hermans R. Impact of cartilage invasion on treatment and prognosis of laryngeal cancer. Eur Radiol. 1996;6:156-169.
39. National Cancer Institute. Hypopharyngeal cancer. National Cancer Institute Treatment Statement for Health Professionals. January 24, 2007. Available at: http://www.meb.uni-bonn.de/cancer.gov/CDR0000062921.html. Accessed April 18, 2007.
40. Thabet HM, Sessions DG, Gado MH, et al. Comparison of clinical evaluation and computed tomographic diagnostic accuracy for tumors of the larynx and hypopharynx. Laryngoscope. 1996;106:589-594.
41. Becker M. Larynx and hypopharynx. Radiol Clin North Am. 1998;36:891-920.
42. Rumboldt Z, Gordon L, Gordon L, et al. Imaging in head and neck cancer. Curr Treat Options Oncol. 2006;7:23-34.
43. Anzai Y, McLachlan S, Morris M, et al. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck. AJNR Am J Neuroradiol. 1994;15:87-94.
44. Anzai Y, Blacwell KE, Hirschowitz SL, et al. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology. 1994;192:709-715.
45. Sigal R, Vogl T, Casselman J, et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) - results of a phase-III multicenter clinical trial. Eur Radiol. 2002;12:1104-1113.
46. Mack MG, Balzer JO, Straub R, et al. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology. 2002;222:239-244.
47. Pharynx (including base of tongue, soft palate and uvula). In: American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002:31-46.
48. Zbaren P, Becker M, Laeng H. Pretherapeutic staging of laryngeal carcinoma. Clinical findings, computed tomography, and magnetic resonance imaging compared with histopathology. Cancer. 1996;77:1263-1273.
49. Hermans R. Staging of laryngeal and hypopharyngeal cancer: value of imaging studies. Eur Radiol. 2006;16:2386-2400.
50. Harrison DF. Pathology of hypopharyngeal cancer in relation to surgical management. J Laryngol Otol. 1970;84:349-367.
51. Kirchner JA. Pyriform sinus cancer: a clinical and laboratory study. Ann Otol Rhinol Laryngol. 1975;84:793-803.
52. Kirchner JA, Owen J. Five hundred cancers of the larynx and pyriform sinus. Results of treatment by radiation and surgery. Laryngoscope. 1977;87:1288-1303.
53. Spector JG, Sessions DG, Emami B, et al. Squamous cell carcinoma of the pyriform sinus: a nonrandomized comparison of therapeutic modalities and long-term results. Laryngoscope. 1995;105:397-406.
54. Willatt DJ, Jackson SR, McCormick MS, et al. Vocal cord paralysis and tumour length in staging postcricoid cancer. Eur J Surg Oncol. 1987;13:131-137.
55. Magnano M, Bongioannini G, Lerda W, et al. Lymph node metastasis in head and neck squamous cell carcinoma: multivariate analysis of prognostic variables. J Exp Clin Cancer Res. 1999;18:79-83.
56. Buckley JG, Maclennan K. Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck. 2000;22:380-385.
57. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990;160:405-409.
58. Ballantyne AJ. Significance of retropharyngeal nodes in cancer of the head and neck. Am J Surg. 1964;108:500-504.
59. Brasilino de Carvalho M. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck. 1998;20:16-21.
60. Alvi A, Johnson JT. Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck. 1997;19:500-505.
61. Leon X, Quer M, Cesar O, et al. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck. 2000;22:680-686.
62. Bhatia R, Bahadur S. Distant metastasis in malignancies of the head and neck. J Laryngol Otol. 1987;101:925-928.
63. Barnes L, Gnepp DR. Diseases of the larynx, hypopharynx and esophagus. In: Barnes L, ed. Surgical Pathology of the Head and Neck. New York: Decker; 1985:293-315.
64. Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx. Laryngoscope. 2001;111:1079-1087.
65. Merino OR, Lindberg RD, Fletcher GH, et al. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer. 1977;40:145-151.
66. Garavello W, Ciardo A, Spreafico R, et al. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132:762-766.
67. Jones AS, Morar P, Phillips DE, et al. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 1995;75:1343-1353.
68. Yousem DM, Hatabu H, Hurst RW, et al. Carotid artery invasion by head and neck masses: prediction with MR imaging. Radiology. 1995;195:715-720.
69. Yu Q, Wang P, Shi H, et al. Carotid artery and jugular vein invasion of oral-maxillofacial and neck malignant tumors: diagnostic value of computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:368-372.
70. Berrino F, Gatta G. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer. 1998;34:2154-2161.
71. Jones AS. Tumors of the hypopharynx. In: Jones AS, Phillips DE, Hilgers FJM, eds. Diseases of the Head and Neck, Nose and Throat. London: Edward Arnold; 1998:230-249.
72. Daisne JF, Duprez T, Weynand B, et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology. 2004;233:93-100.
73. Becker M, Zbaren P, Lang H, et al. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology. 1995;194:661-669.
74. Becker M, Zbaren P, Delavelle J, et al. Neoplastic invasion of the laryngeal cartilage: reassessment of criteria for diagnosis at CT. Radiology. 1997;203:521-532.
75. Williams RG. Recurrent head and neck cancer: the results of treatment. Br J Surg. 1974;61:691-697.
76. Jones KR, Lodge-Rigal D, Reddick RL, et al. Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity. Arch Otolaryngol Head Neck Surg. 1992;118:483-485.
77. Shah JP, Cendon RA, Farr HW, et al. Carcinoma of the oral cavity: factors affecting treatment failure at the primary site and neck. Am J Surg. 1976;132:504-507.
78. Jesse RH, Sugarbaker EV. Squamous cell carcinoma of the oropharynx: why we fail. Am J Surg. 1976;132:435-438.
79. Wong LY, Wei WI, Lam LK, et al. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 2003;25:953-959.
80. Zbaren P, Caversaccio M, Thoeny HC, et al. Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg. 2006;135:838-843.
81. Gussack GS, Hudgin PA. Imaging modalities in recurrent head and neck tumors. Laryngoscope. 1991;101:119-124.
82. Hermans R, Pameijer FA, Mancuso AA. CT findings in chondroradionecrosis of the larynx. AJNR Am J Neuroradiol. 1998;19:711-718.
83. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18] fluoro-D-glucose PET and MR imaging diagnosis. Radiology. 1996;200:135-141.
84. Stokkel MPM, Terhaard CHJ, Hordijk GJ, et al. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med. 1999;26:767-773.
85. Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18 F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope. 1999;109:970-975.
86. Lonneux M, Lawson G, Ide C, et al. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope. 2000;110:1493-1497.
87. Terhaard CH, Bongers V, van Rijk PP, et al. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck. 2001;23:933-941.
88. Wong RJ, Lin DT, Schoder H, et al. Diagnostic and prognostic value of [18 F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol. 2002;20:4199-4208.
89. Hustinx R, Smith RJ, Benard F, et al. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in head and neck. Eur J Nucl Med. 1999;26:1345-1348.
90. Sugawara Y, Zasadny KR, Neuhoff AW, et al. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology. 1999;213:521-525.
91. Keyes JW Jr. SUV: standard uptake or silly useless value? J Nucl Med. 1995;36:1836-1839.
92. Kubota K, Yokoyama J, Yamaguchi K, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging. 2004;31:590-595.
93. Greven K, Williams DW, McGuirt F, et al. Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer. Head Neck. 2001;23:942-946.
94. Bombardieri E, Crippa F. The increasing impact of PET in the diagnostic work-up of cancer patients. In: Freeman L, ed. Nuclear Medicine Annual 2002. Philadelphia, PA: Lippincott Williams; 2002:75-121.
95. Schoder H, Yeung HWD, Gonen M, et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65-72.
96. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369-1379.
97. Martinelli MA, Townsend D, Meltzer CC, et al. Survey of results of whole body imaging using the PET/CT at the University of Pittsburgh Medical Center PET facility. Clin Positron Imaging. 2000;3:161.
98. Beyer T, Antoch G, Bockisch A, et al. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT. J Nucl Med. 2005;46:429-435.
99. Gorospe L, Raman S, Echeveste J, et al. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun. 2005;26:671-687.
100. Vandecaveye V, de Keyzer F, Vander Poorten V, et al. Evaluation of the larynx for tumour recurrence by diffusion-weighted MRI after radiotherapy: initial experience in four cases. Br J Radiol. 2006;79:681-687.
101. Taouli B, Martin AJ, Qayyum A, et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR Am J Roentgenol. 2004;183:677-680.
102. Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology. 2001;220:621-630.
103. Maheshwari SR, Mukherji SK, Neelon B, et al. The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy. AJNR Am J Neuroradiol. 2000;21:1930-1935.
104. Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiologic appearance of the irradiated larynx. Part I. Expected changes. Radiology. 1994;193:141-148.
105. Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiologic appearance of the irradiated larynx. Part II. Primary site response. Radiology. 1994;193:149-154.
106. Mafee MF, Barany M, Gotsis ED, et al. Potential use of in vivo proton spectroscopy for head and neck lesions. Radiol Clin North Am. 1989;27:243-254.
107. Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed. 1991;4:47-52.
108. Star-Lack JM, Adalsteinsson E, Adam MF, et al. In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. AJNR Am J Neuroradiol. 2000;21:183-193.
109. Mukherji SK, Schiro S, Castillo M, et al. Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol. 1997;18:1057-1072.
110. Mukherji SK, Schiro S, Castillo M, et al. Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. AJNR Am J Neuroradiol. 1996;17:1485-1490.
111. Lambre H, Anzai Y, Farahani K, et al. Interventional magnetic resonance imaging of the head and neck and new imaging techniques. Neuroimaging Clin N Am. 1996;6:461-472.
112. Mills PH, Ahrens ET. Theoretical MRI contrast model for exogenous T2 agents. Magn Reson Med. 2007;57:442-447.
113. Bezabeh T, Odlum O, Nason R, et al. Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy. AJNR Am J Neuroradiol. 2005;26:2108-2113.
114. Trotti A, Bellm LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Int J Radiat Oncol Biol Phys. 2003;66:253-262.
115. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys. 2000;47:1-12.
116. Stenson KM, MacCracken E, List M, et al. Swallowing function in patients with head and neck cancer prior to treatment. Arch Otolaryngol Head Neck Surg. 2000;126:371-377.
117. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002;53:23-28.
118. Rosenthall DI, Lewin JS, Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol. 2006;24:2636-2643.
119. Ang KK, Garden AS. Radiotherapy for Head and Neck Cancers. Indications and Techniques. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:135-147.
120. Chao KS, Garden AS, Ozyigit G. Hypopharynx and larynx. In: Chao KS, Apisamthanarax S, Ozyigit G, eds. Practical Essentials of Intensity Modulated Radiation Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:196.
121. Pfister DG, Hu KS, Lefebvre JL. Cancer of the hypopharynx and cervical esophagus. In: Harrison LB, Sessions RB, Hong WK, eds. Head and Neck Cancer. A Multidisciplinary Approach. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:404-454.
122. Zelefsky MJ. Cancer of the hypopharynx. In: Leibel SA, Phillips TL, eds. Textbook of Radiation Oncology. Philadelphia, PA: Saunders; 2004:662.
123. Mendenhall WM, Parsons JT, Stringer SP, et al. Radiotherapy alone or combined with neck dissection for T1-T2 carcinoma of the pyriform sinus: an alternative to conservation surgery. Int J Radiat Oncol Biol Phys. 1993;27:1017-1027.
124. Sessions DG, Ogura JH. Classification of laryngeal cancer. Can J Otolaryngol. 1974;3:489.
125. Amdur RJ, Mendenhall WM, Stringer SP, et al. Organ preservation with radiotherapy for T1-T2 carcinoma of the pyriform sinus. Head Neck. 2001;23:353.
126. Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Can Institute. 1996;88:890-898.
127. Fu KK, Pajak TF, Trotti A. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiol Biol Phys. 2000;48:7-16.
128. Bourhis J, Overgaard J, Audry H. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet. 2006;368:843-854.
129. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol. 2003;21:92-98.
130. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data - MACH-NC Collaborative Group, Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355:949-955.
131. Ang KK, Harris J, Garden AS, et al. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J Clin Oncol. 2005;23:3008-3015.
132. Bush DA, Slater JD, Shin BB, et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest. 2004;126:1198-1203.
133. Bush DA, Slater JD, Garberoglio C, et al. A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray therapy. Cancer J. 2007;13:114-118.
134. Lin R, Hug EB, Schaefer RA, et al. Conformal proton radiation therapy of the posterior fossa: a study comparing protons with three-dimensional planned photons in limiting dose to auditory structures. Int J Radiat Oncol Biol Phys. 2000;48:1219-1226.
135. Lin R, Slater JD, Yonemoto LT, et al. Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy-dose-volume histogram analysis. Radiology. 1999;213:489-494.
136. Slater JD, Yonemoto LT, Mantik D. Proton radiation for treatment of cancer of the oropharynx: early experience at Loma Linda University Medical Center using a concomitant boost technique. Int J Radiat Oncol Biol Phys. 2005;62:494-500.
137. Yuh GE, Loredo LN, Yonemoto LT, et al. Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer J. 2004;10:386-390.
138. Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA. 2005;294:1233-1239.